Literature DB >> 2664172

Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan.

.   

Abstract

Twenty-four different antigens from 6 strains of streptococcus were prepared for skin testing and delayed hypersensitivity testing. The induction of Behçet's disease symptoms by these antigens was studied. Delayed skin reactions to whole cells and cell walls of streptococci were frequently observed in Behçet's disease, but only a few skin reactions were observed in other diseases and healthy controls. The skin reactions to the other bacteria were also strong in Behçet's disease, but the differences between Behçet's disease and the other diseases were not significant. Interestingly, the induction of systemic Behçet's disease symptoms was observed after the streptococcus skin test in 15 of 85 cases tested, but no case of induction by the other bacteria was observed. Our study supports the possible pathogenetic role of certain streptococcal antigens in Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664172

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  28 in total

1.  Diagnostic dilemma between intestinal Behçet disease and inflammatory bowel disease with pyoderma gangrenosum.

Authors:  Cem Evereklioglu
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 2.  Behçet's syndrome pathophysiology and potential therapeutic targets.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Mario Milco D'Elios; Lucia Ciucciarelli; Domenico Prisco; Lorenzo Emmi
Journal:  Intern Emerg Med       Date:  2014-01-12       Impact factor: 3.397

Review 3.  Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.

Authors:  Salih Pay; Ismail Simşek; Hakan Erdem; Ayhan Dinç
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

4.  The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.

Authors:  Ayşe İlksen Colpak; Umut Kalyoncu; Yasemin Gürsoy Özdemir
Journal:  Noro Psikiyatr Ars       Date:  2014-06-01       Impact factor: 1.339

5.  Defining a T-cell epitope within HSP 65 in recurrent aphthous stomatitis.

Authors:  A Hasan; T Shinnick; Y Mizushima; R van der Zee; T Lehner
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

6.  Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome.

Authors:  T Lehner; E Lavery; R Smith; R van der Zee; Y Mizushima; T Shinnick
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

7.  Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.

Authors:  M Stanford; T Whittall; L A Bergmeier; M Lindblad; S Lundin; T Shinnick; Y Mizushima; J Holmgren; T Lehner
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

8.  Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Authors:  Fabricio Souza Neves; Solange Carrasco; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves; Suzana Beatriz Veríssimo de Mello
Journal:  Clin Rheumatol       Date:  2009-08-25       Impact factor: 2.980

9.  Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.

Authors:  B Taşçi; H Direskeneli; P Serdaroglu; G Akman-Demir; M Eraksoy; G Saruhan-Direskeneli
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  Staphylococcus aureus and autoimmune uveitis reactivation in childhood: a possible correlation?

Authors:  Paolo Mora; Erilda Kamberi; Francesca Manzotti; Laura Zavota; Jelka G Orsoni
Journal:  Ital J Pediatr       Date:  2009-11-12       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.